Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IITerminatedNov 13, 2013RopiniroleCross contamination with other products: Sandoz is recalling certain lots of Ropinirole Extended Release Tablets 2 mg due to the potential presence of carryover coming...Sandoz, Inc · D-66458-1Class IITerminatedNov 13, 2013Irinotecan Hydrochloride InjectionSuperpotent Drug: a recent review of the USP revealed that an incorrect calculation was used to determine the amount of irinotecan to use in formulation which will...West-Ward Pharmaceutical Corp. · D-66447-002Class IITerminatedNov 13, 2013Irinotecan Hydrochloride InjectionSuperpotent Drug: a recent review of the USP revealed that an incorrect calculation was used to determine the amount of irinotecan to use in formulation which will...West-Ward Pharmaceutical Corp. · D-66447-001Class IITerminatedNov 13, 2013Amlodipine Besylate TabletsCGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.Mylan Pharmaceuticals Inc. · D-66403-012Class IITerminatedNov 13, 2013Ciprofloxacin TabletsCGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.Mylan Pharmaceuticals Inc. · D-66403-011Class IITerminatedNov 13, 2013Amlodipine Besylate and Benazepril HCl CapsulesCGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.Mylan Pharmaceuticals Inc. · D-66403-010Class IITerminatedNov 13, 2013Amlodipine Besylate and Benazepril HCl CapsulesCGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.Mylan Pharmaceuticals Inc. · D-66403-009Class IITerminatedNov 13, 2013Amlodipine Besylate and Benazepril HCl CapsulesCGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.Mylan Pharmaceuticals Inc. · D-66403-008Class IITerminatedNov 13, 2013Amlodipine Besylate and Benazepril HCl CapsulesCGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.Mylan Pharmaceuticals Inc. · D-66403-007Class IITerminatedNov 13, 2013Amlodipine Besylate and Benazepril HCl CapsulesCGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.Mylan Pharmaceuticals Inc. · D-66403-006Class IITerminatedNov 13, 2013Amlodipine Besylate TabletsCGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.Mylan Pharmaceuticals Inc. · D-66403-005Class IITerminatedNov 13, 2013Ciprofloxacin TabletsCGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.Mylan Pharmaceuticals Inc. · D-66403-004Class IITerminatedNov 13, 2013Lamotrigine TabletsCGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.Mylan Pharmaceuticals Inc. · D-66403-003Class IITerminatedNov 13, 2013Amlodipine Besylate and Benazepril HCl CapsulesCGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.Mylan Pharmaceuticals Inc. · D-66403-002Class IITerminatedNov 13, 2013Amlodipine Besylate TabletsCGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.Mylan Pharmaceuticals Inc. · D-66403-001Class IITerminatedNov 13, 2013Prolia (denosumab) InjectionPresence of Particulate Matter: Visible cellulose fibers were observed in a small number of prefilled syringes during a routine quality examination.Amgen, Inc. · D-66318-001Class IITerminatedNov 13, 2013Extended Phenytoin Sodium CapsulesFailed dissolution specifications; 18 month CRTAmneal Pharmaceuticals of New York, LLC. · D-66014-001Class IITerminatedNov 6, 2013Bevacizumab 25mg/mLLack of Assurance of Sterility: Fallon Pharmacy recalled Bevacizumab 25mg/mL due to sterility assurance concerns based on testing of this lot by a third party lab...Fallon Wellness Pharmacy Llc · D-66200-001Class IITerminatedOct 30, 2013Albuterol Sulfate Inhalation SolutionLack of Assurance of Sterility: Nephron Pharmaceuticals Corporation conducted a routine periodic aseptic process simulation and discovered bacterial growth in a number...Nephron Pharmaceuticals Corp. · D-66462-001Class IIITerminatedOct 30, 2013Ketoconazole ShampooSubpotentTolmar, Inc. · D-66402-001Class IIITerminatedOct 30, 2013GILTUSS ANTITUSSIVE EXPECTORANT AND NASAL DECONGESTANTSubpotent; phenylephrine HClHi-Tech Pharmacal Co., Inc. · D-66207-001Class IITerminatedOct 23, 2013Concentrated MotrinPresence of Foreign Substance: process-related particulates which may be associated with the raw materials were observedMcneil Consumer Healthcare, Div Of Mcneil-ppc, Inc. · D-66272-001Class IIITerminatedOct 16, 2013Hydroxychloroquine Sulfate TabletsFailed Tablet/Capsule Specifications: Sandoz is recalling one lot of Hydroxychloroquine Sulfate Tablets, USP, 200mg, due to illegibility of the logo on some tablets.Sandoz Incorporated · D-66373-001Class IITerminatedOct 16, 2013Next Choice" One Dose Emergency ContraceptiveFailed Tablet/Capsule Specifications: Multiple complaints for push through tablet breakage.Watson Laboratories Inc · D-66360-001Class IITerminatedOct 16, 20130.5% Bupivacaine HCl and Epinephrine 1:200Lack of Assurance of Sterility; potential for vial breakageHospira Inc. · D-66295-001Class IITerminatedOct 9, 2013Oxycodone and Acetaminophen TabletsPresence of Foreign Tablets/Capsules: 20 tablets of Oxycodone/APAP 7.5/500 mg were found in a sealed 100 count bottle of Oxycodone and Acetaminophen Tablets, USP 10/650...Watson Laboratories Inc · D-66251-001Class IITerminatedOct 9, 2013SIH-Testosterone Cypionate 200 mg/mL InjectableLack of Assurance of Sterility: concerns of sterility assurance with the pharmacy's independent testing laboratoryApothecary Shoppe · D-66241-002Class IITerminatedOct 9, 2013Estradiol 1.25 mgLack of Assurance of Sterility: concerns of sterility assurance with the pharmacy's independent testing laboratory.Apothecary Shoppe · D-66241-001Class IITerminatedOct 9, 20135% Lidocaine HCl and 7.5% Dextrose InjectionPresence of Particulate Matter; report of visible particulates in the glass ampuleHospira Inc. · D-66201-001Class IITerminatedOct 9, 2013HistamineLack of Assurance of Sterility:The product lots are being recalled due to laboratory results (from a contract lab) indicating microbial contamination. The FDA was...Triangle Compounding · D-1069-2013Class IITerminatedOct 9, 2013Sodium Phosphate InjectableLack of Assurance of Sterility:The product lots are being recalled due to laboratory results (from a contract lab) indicating microbial contamination. The FDA was...Triangle Compounding · D-1068-2013Class IIITerminatedOct 9, 2013VenlafaxineFailed Dissolution Specification:12 hour time point at 18 months of product shelf life.Osmotica Pharmaceutical Corp · D-1067-2013Class IITerminatedOct 9, 2013Ifosfamide Injection 3g/60 mLTemperature abuse: Certain vials of Ifosfamide IV products were not refrigerated at certain Amerisource Bergen Drug Corp distribution centers.AmeriSource Bergen · D-1066-2013Class IITerminatedOct 9, 2013Ifosfamide Injection 1g/20mLTemperature abuse: Certain vials of Ifosfamide IV products were not refrigerated at certain Amerisource Bergen Drug Corp distribution centers.AmeriSource Bergen · D-1065-2013Class IITerminatedOct 9, 2013Acetaminophen TabletsCGMP Deviations: The recalled acetaminophen tablet lot was not manufactured under current good manufacturing practices as noted by a recent inspection of the...Marlex Pharmaceuticals, Inc. · D-1064-2013Class IITerminatedOct 2, 2013Walgreens Progesterone in Ethyl Oleate 50 mg per mL InjectionLack of Assurance of Sterility: Walgreens Specialty Pharmacy is recalling one lot of Progesterone in Ethyl Oleate sterile injection due to concerns of sterility...Walgreens Co · D-1063-2013Class IITerminatedOct 2, 2013Pyridostigmine Bromide Tablets 60 mgFailed Stability Specifications: Pyridostigmine Bromide tablets, is being recalled due to an out of specification test result during stablity testing.Core Pharma Llc · D-1062-2013Class IIITerminatedSep 25, 2013Hydrocodone Bitartrate and Acetaminophen TabletsDefective Container: Defective bottles may not have tamper evident seals properly seated, and therefore it may be difficult to determine if the product had been opened...Watson Laboratories Inc · D-1061-2013Class IITerminatedSep 25, 2013Hydroxocobalamin MDV 5 mg/mLLack of Assurance of Sterility: The pharmacy is recalling one lot of Hydroxocobalamin MDV 5mg/mL due to failed sterility results by a third party contract testing lab...Northern New England Compounding Pharmacy LLC · D-1060-2013Class IITerminatedSep 25, 2013Vancomycin PFLack of Assurance of Sterility: Avella Specialty Pharmacy is recalling bevacizumab and vancomycin due to concerns of sterility assurance with the specialty pharmacy's...Avella of Deer Valley, Inc. · D-1059-2013

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.